Acronym:
CTC
ACTRN/NCT /ethics:
Scientific title:
Identification of biomarkers through Analysis of circulatingtumour cells in Australian men with prostate cancer
Summary of trial and patient characteristics
| Cancer Type | Prostate | ||
|---|---|---|---|
| Trial Type | Early detection, diagnosis, prognosis | ||
| Phase | All phases | Tumour Stream | Prostate |
| Age Range | 18 years and older | Cancer Stage | All stages |
| Sex | Male | Anticipated Start Date | |
| Molecular Target | Anticipated End Date | ||
| Cancer Type | Prostate |
|---|---|
| Trial Type | Early detection, diagnosis, prognosis |
| Phase | All phases |
| Age Range | 18 years and older |
| Sex | Male |
| Molecular Target | |
| Tumour Stream | Prostate |
| Cancer Stage | All stages |
| Anticipated Start Date | |
| Anticipated End Date |
Trial Summary
Identification of biomarkers through analysis of circulating tumour cells in Australian men with prostate cancer.
Lay Summary
Identification of biomarkers through Analysis of circulatingtumour cells in Australian men with prostate cancer
Sponsor / Cooperative group
C Hocking
Participating Hospitals
| Hospital | Clinical Trial Coordinator | Phone | Principal Investigator | Recruitment Status | |
|---|---|---|---|---|---|
| Ashford Cancer Centre Research | Helen Daykin | hdaykin@adelaidecancercentre.com.au | 08 8292 2240 | Not Yet Recruiting |